ABOUT USdot CONTACTdot LOG IN

Archives for the 'Blog' Category

Langer Sheds Orthotics Business to Cut the Fat

Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to The Orthotic Group (TOG), a manufacturer of prescription custom foot […]

27 October 2008 | Blog, news2, feature2 | No Comments

Nothing But Sunshine and Roses for Endologix, Save its Share Price

Endologix, developer of a treatment for abdominal aortic aneurysms (AAA), saw revenues increase 42% in its third quarter. The company reported $9.4 million in sales and expects “at least” $10 million in fourth quarter revenue. […]

24 October 2008 | Blog, news1, feature2 | No Comments

Candela Explores Strategic Alternatives in Challenging Aesthetics Market

First Quarter Results: Revenues at Candela Corporation, a maker of aesthetic lasers, decreased 24 percent year-over-year, to $26.9 million in the most recent quarter from $35.5 million last year. The decrease in revenues took its toll […]

23 October 2008 | Blog, news1, feature1 | 4 Comments

Business as Usual for Endologix as it Considers $98 Million Buyout

More good news from Endologix, the Irvine, CA-based company mulling over a $98 million buyout bid from hedge fund Elliott Associates. This week, the company’s IntuiTrak Delivery System was approved by the FDA. The System will […]

22 October 2008 | Blog, news1 | 1 Comment

NxStage Medical Signs Long-Term Supply Agreement with Renal Advantage

NxStage Medical has signed a long-term product supply agreement with Renal Advantage (RAI), the fourth largest provider of dialysis services in the U.S. Under the terms of the agreement, NxStage will supply the Streamline airless […]

21 October 2008 | Blog, news1 | No Comments

CoreValve Prevails in German Patent Infringement Lawsuit with Edwards

A German Federal Court has found that CoreValve’s ReValving system (for transcatheter aortic valve replacement) does not infringe any of the claims of the Andersen patent held by Edwards Lifesciences. That patent relates to the […]

20 October 2008 | Blog, news2 | No Comments

Elliott Associates Submits $98 Million Lowball Bid for Endologix

The New York-based hedge fund, Elliott Associates, has offered to buy all of the outstanding shares of Endologix for $98 million or $2.25 per share. The unsolicited proposal came yesterday. Endologix stock, which had hovering […]

17 October 2008 | Blog, news2 | 2 Comments

Treating Disc Degeneration from the Inside Out: New Preclinical Data from ISTO Technologies

ISTO Technologies announced positive preclinical data for its spinal disc repair therapy, NuQu. In collaboration with the University of California San Francisco (UCSF), ISTO is investigating potential applications of the company’s core cell-based platform technology. ISTO’s […]

17 October 2008 | Blog, Member Spotlight, news1, feature1 | No Comments

Kinetic Concepts Gets FDA Clearance For Tissue Matrix

Kinetic Concepts (KCI) has received FDA 510(k) clearance for its LifeCell Tissue Matrix. The matrix is used to treat chronic, trauma, surgical and other acute wounds. The product utilizes the company’s Strattice technology, a sterile […]

16 October 2008 | Blog, news1 | No Comments

Medtech Insight: In3 East

Meet the most important people in medical technology at In3 East, the largest East Coast strategic partnership and investment meeting for senior-level medical technology executives. Hundreds of venture capital companies and medical technology companies will […]

15 October 2008 | Blog, Member Spotlight | 2 Comments

Search

Navigation

Meta

Archives

Seeking Alpha Certified
Equities Building Research Building Enterprises Building Resources Building